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THE LINK BETWEEN
PREVIOUS PERCUTANEOUS
CORONARY INTERVENTION
AND CORONARYARTERY
BYPASS GRAFT RISK
To the Editor:
We read with interest the publica-
tion by Massoudy and colleagues,1
who observed a higher rate of in hospi-
tal mortality and major adverse cardiac
events in patients undergoing coronary
artery bypass graft surgery with two or
more previous percutaneous coronary
interventions (PCIs). We wish to
raise a few important issues that need
to be considered when interpreting
this study. First, multivariate analysis
has limitations as a statistical tool in
a context such as this, where a vastly
disproportionate number of patients
in each group could lead to inappropri-
ate identification of meaningful predic-
tors. Second, inasmuch as there is
minimal clinical characterization of
patients in this study, the reasons for
initial multivessel PCI are likely to be
important and may reflect patients un-
dergoing PCI after being thought to
be at too high a risk for initial coronary
bypass surgery or being undertaken as
urgent cases. Finally, another explana-
tion for increased events in this cohort
may be that these patients have de-
clared themselves as a high-risk popu-
lation, having had unsuccessful
medical therapy and PCI,2 and not as
a direct consequence of prior stenting
alone.
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Reply to the Editor:
We read with interest the remarks of
Bhindi and Omerod regarding our arti-
cle.1 We agree that the design of the
study inherits a number of limitations.
For example, the amount of variables
available in the databases was very lim-
ited. Therefore, clinical characteriza-
tion of patients could not be detailed.
A randomized study or prospective
data acquisition would certainly reduce
or abolish the limitations of the retro-
spective study. A prospective study
is, indeed, planned, but its accomplish-
ment raises a number of organizational
and structural problems.
Questioning the reasons for initial
multivessel percutaneous coronary in-
tervention (PCI) is, indeed, very inter-
esting. According to the American
Heart Association guidelines, coro-
nary artery bypass grafting (CABG)
is the recommended therapy in 3-ves-
sel coronary artery disease.2 The in-
creased event rate observed in the
group with multiple prior PCIs thus
supports published expert opinion
and suggests that CABG should have
been performed earlier. We fully
agree, however, that PCI is often per-
formed in urgent cases such as acute
myocardial infarction, which, indeed,
represent high-risk, if not too high-
risk, cases for acute CABG.
Finally, according to our mulitcen-
ter data, having had unsuccessful prior
single PCI and medical therapy does
not render a patient high risk at sub-
sequent CABG. Only when PCI is
repeatedly applied or extended to other
vessel territories does the risk at subse-
quent CABG increase.1 Therefore,
earlier referral of patients with unsuc-
cessful PCI for CABG may prevent
the transition of patients to a higher
risk class and avoid disadvantageous
results at subsequent CABG.
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CONTROLLED STUDIES OF
PREOPERATIVE STATIN
THERAPY FOR PREVENTION
OF POSTOPERATIVE
MORTALITY IN CARDIAC
SURGERY
To the Editor:
We read with great interest an article
by Tabata and associates,1 because we2
previously performed a meta-analysis
of controlled studies of preoperative
statin therapy for postoperative mortal-
ity in cardiac surgery. Tabata and09
Letters to the EditorFIGURE 1. Postoperative mortality among patients undergoing cardiac surgery assigned to preoperative statin therapy versus control. SE, Standard error; IV,
inverse variance; CI, confidence interval.collaborators1 showed that preopera-
tive statin use was associated with
lower mortality (adjusted odds ratio
[OR], 0.25; 95% confidence interval
[CI], 0.12–0.54; P ¼ .0004) in 1389
patients without coronary artery dis-
ease who undewent cardiac surgery.
Meanwhile, our previous pooled anal-
ysis of ORs from 3 randomized con-
trolled trials and adjusted ORs from 6
observational controlled studies (rep-
resenting 18,637 patients) demon-
strated a statistically significant 24%
reduction in postoperative mortality
with preoperative statin therapy rela-
tive to control (pooled OR, 0.76;
95% CI, 0.64–0.90; P < .01).
Because several controlled studies in-
cluding the study by Tabata and col-
leagues1 have been published to date
since we2 performed the meta-analysis,
we herein updated our previous meta-
analysis.
Our comprehensive search identi-
fied 4 randomized controlled trials
that reported postoperative mortality
and 9 observational controlled trials
that stated adjusted ORs for postoper-
ative death. We excluded observa-
tional controlled trials that reported
merely crude mortality or a crude OR
for death. Pooled analysis of the 13
studies (representing 24,039 patients)
demonstrated a statistically significant
33% reduction in postoperative mor-The Jourtality with preoperative statin therapy
relative to control in the fixed-effects
model (pooled OR, 0.67; 95% CI,
0.54–0.83; P ¼ .0002) (Figure 1).
There was minimal study heterogene-
ity (P ¼ .30 by standard c2 tests) and
accordingly little difference in the
pooled result from random-effects
modeling (pooled OR, 0.64; 95% CI,
0.49–0.82; P ¼ .0006). Sensitivity
analyses were performed to assess
the contribution of each study to the
pooled estimate by excluding individ-
ual studies one at a time and recalcu-
lating the pooled OR estimates for
the remaining studies. In general, ex-
clusion of any single study from the
analysis did not substantively alter
the overall result of our analysis.
There was no evidence of significant
publication bias (P ¼ .7143 by an ad-
justed rank-correlation test). The re-
sults of our analysis suggest that
preoperative statin therapy may re-
duce postoperative mortality by 33%
over control in patients undergoing
cardiac surgery, which strengthen the
results of the study by Tabata and co-
workers.1
The present meta-analysis included
4 relatively small randomized con-
trolled trials that were composed of
low-risk patients because their primary
end point was not mortality. Very few
events (postoperative deaths) occur innal of Thoracic and Cardiovascular Sursuch trials, and thus the risk estimate
has inadequate statistical power.
Therefore, we performed a meta-
analysis of not merely randomized
controlled trials but also observational
controlled studies. To minimize con-
founding effects, we carefully selected
merely high-quality observational
studies that reported the adjusted
OR for postoperative death and in-
cluded them in our meta-analysis. A
large multicenter randomized con-
trolled trial consisting of high-risk pa-
tients, however, is needed to confirm
the results of the present updated
meta-analysis.
Hisato Takagi, MD, PhD
Takuya Umemoto, MD, PhD
Department of Cardiovascular
Surgery
Shizuoka Medical Center
Shizuoka, Japan
References
1. Tabata M, Khalpey Z, Cohn LH, Chen FY,
Bolman RM 3rd, Rawn JD. Effect of preoperative
statins in patients without coronary artery disease
who undergo cardiac surgery. J Thorac Cardiovasc
Surg. 2008;136:1510-3.
2. Takagi H, Kawai N, Umemoto T. Preoperative sta-
tin therapy reduces postoperative all-cause mortality
in cardiac surgery: a meta-analysis of controlled
studies. J Thorac Cardiovasc Surg. 2009;137:
e52-3.
doi:10.1016/j.jtcvs.2009.05.027gery c Volume 138, Number 3 791
